These results suggest that REG3A promotes tumor growth in simple in vitro systems but suppresses tumor formation in vivo by regulating O-GlcNAcylation, a process shaped by systemic metabolism and tissue interactions (Figure 3). The gene discussed is REG3A; the disease is neoplasm.